Translational Oncology and Cancer Immunology

All Items

• Co-mutation patterns and survival associations in lung cancer: a comparative analysis of Swedish and global cohorts

  Nicholas Karlowatz, Linda Köhn, Cedric Patthey, Jonas Nilsson, Mikael Johansson

  836-844

• Tools for providing information to patients about high-tech medical resources for treatment of cancer

  Julie Gehl, Tatiana Michel, Erik Rokkones, Soleakhena Ken, Gregor Sersa, Irene Torres-Espallardo, Ester Orlandi, Laura Ridolfi, Nina Schmidt, Ingrid Kruecken, Barbara Leonardi, Margareta Haag, Aurélie Garcin, Anne-Laure Giraudet, Sandrine Lavallé, Colin Patrick Cantwell, Alexander Jorge Cortez, Chiara Marazzi, Roger Olofsson Bagge, Massimiliano Petrini, Francesca Bonifazi, Vincent Bourbonne, Frédéric Courbon, Ibrahim Edhemović, Lisa Licitra, Sergio Roman-Roman, Jean-Yves Blay, Author study group

  818-835

• Pre-operative circulating tumour DNA in high-risk primary cutaneous melanoma: prospective feasibility in molecular pathology

  Magnús Pétur Bjarnason Obinah, Estrid Høgdall, Tim Svenstrup Poulsen, Karin Dreisig, Thomas Litman, Christoffer Johansen, Stig Egil Bojesen, Lisbet Rosenkrantz Hölmich

  737-742

• The false-negative rate of sentinel lymph node biopsy and its related factors in early-stage cervical cancer: a systematic review and meta-analysis

  Chao He, Fei Li, Min He, Jia Li

  213-227

• Differences in tumor mutational burden assessment: a national ring trial

  Christine Federspiel Secher, Christina Westmose Yde, Britt Elmedal Laursen, Estrid Høgdall, Henriette Sylvain Thomsen, Tim Svenstrup Poulsen, Mads Sønderkær, Tina Kringelbach, Mads Malik Aagaard Jørgensen, Rikke Frydendahl Sick Olsen, Anja Elaine Sørensen, Christian Baudet, Magnús Halldór Gíslason, Michael Knudsen, Ida Kappel Buhl

  178-180

• The rise of 3D spheroids in radiobiology for assessing tumour radioresistance

  Alexandra Charalampopoulou, Fabrizio De Luca, Giuseppe Magro, Niloufar Matoor, Amelia Barcellini, Giorgio Butella , Giovanni Battista Ivaldi , Sara Lillo, Lorenzo Manti, Alessio Mereghetti , Paola Tabarelli De Fatis , Maria Grazia Bottone , Angelica Facoetti

  46-58

• Revisiting insulin resistance in human cancer cachexia – a systematic review and meta-analysis

  Jonas Sørensen, Anna Hammershøi, Joan Miquel Màrmol, Louise Lang Lehrskov, Ole Nørgaard, Lykke Sylow

  1648-1656

• Comparative analysis of molecular targeted radiosensitizers in 2D and 3D cancer cell line models

  Michael Ramirez Parra, Antje Dietrich, Manuel Pfeifer, Henning Willers, Mechthild Krause, Nathalie Borgeaud

  1631-1639

• L1CAM/CD171 expression in human tumors and its association with tumor phenotype

  Seyma Büyücek, Magalie Lurati, Katharina Möller, Florian Fiehweger, Ria Schlichter, Anne Menz, Andreas M Luebke, Viktor Reiswich, Martina Kluth, Claudia Hube-Magg, Andrea Hinsch, Florian Lutz, Sören Weidemann, Frank Jacobsen, David Dum, Christian Bernreuther, Patrick Lebok, Guido Sauter, Andreas H. Marx, Ronald Simon, Christoph Fraune, Natalia Gorbokon, Eike Burandt, Sarah Minner, Stefan Steurer, Till S Clauditz, Till Krech, Viktoria Chirico, Maximilian Lennartz

  1621-1630

• Predicting neoadjuvant chemotherapy treatment response in hormone- receptor-positive/HER2-negative breast cancer – results from the Swedish SCAN-B population-based cohort

  Niklas Loman, Hani Saghir, Siker Kimbung

  1577-1589
• 

  Efficacy of argon–helium cryoablation combined with PD-1 inhibitors in non-small cell lung cancer

  Zheng Zheng, Bo Tian, Yonghui An, Wei Wang, Miaomiao Zhang, Wenhua Ma, Ying Guo, Yao Fan, Na Li

  1523-1530

• Cost of treatment of metastatic non-small lung cancer in Sweden, 2011–2023

  Kun Kim, Michael Sweeting, Nils Wilking, Linus Mattias Jönsson

  1473-1481

• Determining the effects of hyperthermia on the tumor and acute normal tissue response of FLASH radiation

  Priyanshu Manojkumar Sinha, Line Kristensen, Charlemagne Asonganyi Folefac, Lars Hjorth Præstegaard, Lone Hoffmann, Per Rugaard Poulsen, Michael Robert Horsman, Brita Singers Sørensen

  1437-1445

• Natural killer cell activity in prostate cancer patients treated with curative radiotherapy with or without androgen deprivation therapy: an observational study

  Stine V. Eriksen, Christine V. Madsen, Signe Timm, Ahmed H. Zedan, Louise Raunkilde, Torben F. Hansen, Line Nederby

  1420-1429
• 

  Up-regulation of intra-tumour LDLR gene expression is associated with statin treatment and better prostate cancer prognosis

  Kia Eistrup Fonfara, Jacob Fredsøe, Benedicte Parm Ulhøi, Signe Borgquist, Michael Borre, Karina Dalsgaard Sørensen

  1371-1380

• Dual-tracer autoradiographic analysis of glucose metabolism and hypoxia in orthotopic and PDX tumor models

  Morten Busk, Martin K Thomsen, Jens Overgaard, Martin F Berthelsen, Henrik Hager, Johan Bussink, Kim V Hansen, Steen Jakobsen, Jacob Kinggaard Lilja-Fischer, Ebbe Boedtkjer, Mikkel H Vendelbo

  1152-1159

• Mutational profile of oropharyngeal squamous cell carcinoma in relation to HPV, tobacco smoking and prognosis with validation in the DAHANCA 19 randomized trial

  Jacob Lilja-Fischer, Morten Horsholt Kristensen , Pernille Lassen, Torben Steiniche, Trine Tramm, Magnus Stougaard, Anders Frederiksen, Benedicte Ulhøi, Jan Alsner, Kasper Toustrup, Christian Maare, Jørgen Johansen, Hanne Primdahl, Claus Andrup Kristensen, Maria Andersen, Jesper Grau Eriksen, Jens Overgaard

  1129-1135

• Fixation method influences FLASH skin sparing in an in vivo leg model

  Line Kristensen, Cathrine Overgaard, Jacob Johansen, Anna Holtz Hansen, Niels Bassler, Per Rugaard Poulsen, Brita Singers Sørensen

  1029-1034

• Preclinical study of reirradiation with hyperthermia in recurrent murine tumors and normal mouse skin

  Charlemagne A Folefac, Priyanshu M. Sinha, Niels Bassler, Brita S. Sørensen, Michael R. Horsman

  972-978

• TCHL – a phase II neo-adjuvant study assessing TCH (docetaxel, carboplatin and trastuzumab) and TCHL (docetaxel, carboplatin, trastuzumab and lapatinib) in HER-2 positive breast cancer patients: a 5-year follow-up with serum biomarker analysis

  John Crown, Alex J. Eustace, Denis M. Collins, Maccon Keane, Linda Coate, John Kennedy, Seamus O'Reilly, Catherine Kelly, Miriam O'Connor, Michael Martin, Conleth Murphy, Karen Duffy, Janice Walshe, Giuseppe Gullo, Thamir Mahgoub, Alberto Alvarez-Iglesias, Imelda Parker, Vicky Donachie, Ausra Teiserskiene, Stephen F. Madden, Brian Moulton, Norma O'Donovan, Bryan T. Hennessy

  751-760

• Multi-dimensional interpretable deep learning-radiomics based on intra-tumoral and spatial habitat for preoperative prediction of thymic epithelial tumours risk categorisation

  Yuhua Yang, Jia Cheng, Can Cui, Huijie Huang, Meiling Cheng, Jiayi Wang, Minjing Zuo

  391-405

• The clinical utility of circulating human papillomavirus across squamous cell carcinomas

  Karen-Lise G. Spindler, Anne V. Jakobsen, Jesper G. Eriksen, Lars Fokdal, Marianne Nordsmark, Lise B. J. Thorsen, Karen L. Wind, Anna C. Lefevre, Jens Overgaard

  1-12

• High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providers

  Joost G.E. Verbeek, Leyla Azarang, Luis E. Pilli, Vincent M.T. de Jong, Agnes Jager, Sabine C. Linn, Valesca P. Retèl, Wim H. van Harten

  701-709

• Germline variants in patients diagnosed with pediatric soft tissue sarcoma

  Synnøve Yndestad, Hans Kristian Haugland, Dorota Goplen, Dorota Wojcik, Stian Knappskog, Per Eystein Lønning

  586-591

• CD3+ and CD8+ T cell-based immune cell score as a prognostic factor in clear-cell renal cell carcinoma

  Jonne Åkerla, Olli Helminen, Juha P. Väyrynen, Anne Parkkinen, Hilma Järvenpää, Jan Böhm, Maarit Ahtiainen, Heikki Seikkula

  105-110

• KIDNEY-PAGER: analysis of circulating tumor DNA as a biomarker in renal cancer – an observational trial. Study protocol

  Laura Iisager, Johanne Ahrenfeldt, Anna Krarup Keller, Tommy Kjærgaard Nielsen, Niels Fristrup, Iben Lyskjær

  51-55